Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nutrition
Published in: European Journal of Nutrition 4/2016

01-06-2016 | Erratum

Erratum to: Profile of European adults interested in internet-based personalised nutrition: the Food4Me study

Authors: Katherine M. Livingstone, Carlos Celis-Morales, Santiago Navas-Carretero, Rodrigo San-Cristobal, Clare B. O’Donovan, Hannah Forster, Clara Woolhead, Cyril F. M. Marsaux, Anna L. Macready, Rosalind Fallaize, Silvia Kolossa, Lydia Tsirigoti, Christina P. Lambrinou, George Moschonis, Magdalena Godlewska, Agnieszka Surwiłło, Christian A. Drevon, Yannis Manios, Iwona Traczyk, Eileen R. Gibney, Lorraine Brennan, Marianne C. Walsh, Julie A. Lovegrove, J. Alfredo Martinez, Wim H. Saris, Hannelore Daniel, Mike Gibney, John C. Mathers

Published in: European Journal of Nutrition | Issue 4/2016

Login to get access

Excerpt

In the original published article Fig. 1 is incorrect. The correct version of the Fig. 1 is given below: …
Metadata
Title
Erratum to: Profile of European adults interested in internet-based personalised nutrition: the Food4Me study
Authors
Katherine M. Livingstone
Carlos Celis-Morales
Santiago Navas-Carretero
Rodrigo San-Cristobal
Clare B. O’Donovan
Hannah Forster
Clara Woolhead
Cyril F. M. Marsaux
Anna L. Macready
Rosalind Fallaize
Silvia Kolossa
Lydia Tsirigoti
Christina P. Lambrinou
George Moschonis
Magdalena Godlewska
Agnieszka Surwiłło
Christian A. Drevon
Yannis Manios
Iwona Traczyk
Eileen R. Gibney
Lorraine Brennan
Marianne C. Walsh
Julie A. Lovegrove
J. Alfredo Martinez
Wim H. Saris
Hannelore Daniel
Mike Gibney
John C. Mathers
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 4/2016
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-016-1175-3

Other articles of this Issue 4/2016

European Journal of Nutrition 4/2016 Go to the issue

Original Contribution

Decreased rates of operant food self-administration are associated with reward deficits in high-fat feeding mice

Original Contribution

Individual and collective factors predicting change in diet quality over 3 years in a subset of older men and women from the NuAge cohort

Original Contribution

Sensitivity to reward is associated with snack and sugar-sweetened beverage consumption in adolescents

Original Contribution

Effects of triacylglycerol structure and solid fat content on fasting responses of mice

Original Contribution

MnSOD and CAT polymorphisms modulate the effect of the Mediterranean diet on breast cancer risk among Greek-Cypriot women

Original Contribution

Phytochemical uptake following human consumption of Montmorency tart cherry (L. Prunus cerasus) and influence of phenolic acids on vascular smooth muscle cells in vitro
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits